Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Assets: 2022-2024

Historic Assets for Immunocore Holdings (IMCR) over the last 3 years, with Dec 2024 value amounting to $1.0 billion.

  • Immunocore Holdings' Assets rose 1.65% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 1.65%. This contributed to the annual value of $1.0 billion for FY2024, which is 69.10% up from last year.
  • Latest data reveals that Immunocore Holdings reported Assets of $1.0 billion as of FY2024, which was up 69.10% from $597.0 million recorded in FY2023.
  • Immunocore Holdings' 5-year Assets high stood at $1.0 billion for FY2024, and its period low was $526.8 million during FY2022.
  • Moreover, its 3-year median value for Assets was $597.0 million (2023), whereas its average is $711.1 million.
  • Data for Immunocore Holdings' Assets shows a peak YoY skyrocketed of 69.10% (in 2024) over the last 5 years.
  • Yearly analysis of 3 years shows Immunocore Holdings' Assets stood at $526.8 million in 2022, then rose by 13.33% to $597.0 million in 2023, then spiked by 69.10% to $1.0 billion in 2024.